As the COVID-19 pandemic tightens its grip, it’s imperative to find effective treatment options and vaccines.
As the go-to expert in drug delivery, Aptar Pharma can leverage therapeutic insights, regulatory expertise and a wide portfolio of systems and services to accelerate and derisk our customer’s drug development process. In the end, we can help them transform ideas into new market opportunities that can improve and save patient lives.
In this webinar, we will review the options for therapeutic and vaccine treatment strategies using the nasal and injectable drug delivery routes. We will also discuss the rationale of drug delivery targets in the upper and lower airways and the selection of the appropriate device platform that drives formulation development.
We will also explore injectable options, highlight the key considerations for global vaccination programs, how to select the best packaging configuration for parenteral drug delivery and present Aptar Pharma’s coated elastomer offering.
Key Learning Objectives
- Review treatment options for nasal and injectable drug delivery routes
- Understand formulation and device considerations for respiratory drug delivery
- Develop a strategy to accelerate lead injectable candidate selection for early clinical trials
